Treatment of tuberculous meningitis in adults: Is the duration of intensive-phase therapy adequate?
Moodley S, Dlwati MS, Bhigjee AI
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde · 2021-04
Abstract
Tuberculous meningitis (TBM) results in considerable morbidity and mortality, especially in developing countries such as South Africa. Treatment regimens have been extrapolated from treatment for pulmonary tuberculosis, and the intensive-phase duration of 2 months may be inadequate for treatment of patients with TBM. We highlight this situation with a case report of a patient with TBM whose illness progressed after institution of the maintenance phase of treatment. We propose that the intensive-phase treatment of TBM be revisited with regard to duration of treatment, choice of drugs during continuation-phase therapy, or both.
MeSH terms
- Humans
- Tuberculosis, Meningeal
- Disease Progression
- Antitubercular Agents
- Treatment Outcome
- Time Factors
- Adult
- South Africa
- Female